POSTER SESSION V Wednesday, March 10, 2004   —  9:30 AM - 12:00 Noon EXHIBIT HALL B and C BREAST PATHOLOGY 21 A Fluorescence In Situ Hybridization Study of ETV6-NTRK3 Fusion Gene in Secretory Breast Carcinoma (153) N Makretsov, M He, PHB Sorensen, M Hayes, S Chia, DG Huntsman - Genetic Pathology Evaluation Centre of the University of BC, Vancouver, BC, Canada; British Columbia Research Institute for Children and Women Health, Vancouver, BC, Canada; BC Cancer Agency, Vancouver, BC, Canada 22 Expression of Mismatch Repair Proteins in Colloid Carcinoma of the Breast (169) H Nassar, L Fathallah, J Antoine, E Levi, O Basturk, NV Adsay - Wayne State University, Harper University Hospital and the Karmanos Cancer Institute, Detroit, MI; VA Medical Center, Detroit, MI 23 Conventional Versus Cellular Mucinous Breast Carcinoma: A Follow-Up and Immunohistochemical Study of Neuroendocrine and Prognostic Markers (75) O Alassi, U Raju - Henry Ford Hospital, Detroit, MI 24 C-Kit Protein Expression in Adenoid Cystic Carcinoma of the Breast (158) C Matte, DW Visscher, C Reynolds - Charles Lemoyne Hospital, Montreal, QC, Canada; Mayo Clinic, Rochester, MN 25 Expression of c-Kit in Adenoid Cystic Carcinoma of the Breast (99) GM Crisi, SA Marconi, G Makari-Judson, RA Goulart - Baystate Medical Center, Springfield, MA; Tufts University School of Medicine, Boston, MA 26 Increased c-kit Expression in Malignant Mammary Phyllodes Tumors (204) GMK Tse, PCW Lui, AWI Lo, TC Putti, RS Scolyer, CS Lee - Chinese University of Hong Kong, Shatin, Hong Kong; United Christian Hospital, Kowloon, Hong Kong; National University Hospital, Singapore; University of Sydney, Sydney, Australia 27 Role of Wnt-1 Induced Secreted Protein-2 (WISP-2) in Breast Cancers and Correlation of Its Expression with Hormone Receptors (214) HT Yee, G Wang, CG Lau, L Chiriboga, PA Ying, AJ Levine, KM Tchou-Wong - New York University, School of Medicine, New York, NY; University of Medicine and Dentistry of New Jersey, Newark, NJ 28 Expression of the Gamma-Synuclein (SNCG) Gene Product in Human Malignant Breast Tissues and Their Correlation with Histopathological Markers of Cell Proliferation, Differentiation and Apoptosis (151) P Makarla, MH Saboorian, F Ansari, D Wanzer, R Ashfaq - University of Texas Southwestern Medical Center at, Dallas, TX; Parkland Health & Hospital Systems, Dallas, TX 29 Insulin-Like Growth Factors Are Prognostic Factors in Breast Cancer: Associations with Estrogen Receptor Alpha and Beta, and Apoptotic Factors (95) YJ Choi - Yale University Schoolof Medicine, New Haven, CT 30 Role of Insulin-Like Growth Factor 1-Receptor (IGF-1R), PTEN, Akt, BAD, and Caspase-3 in Lymph-Node Negative Breast Carcinoma (172) G Peiro, M Niveiro, E Adrover, MF Peiro, A Paya, FI Aranda - Hospital General Universitari, Alacant, Spain 31 Cigarette Smoking and Metallothionein Expression in Breast Cancer (115) LM Gallicchio, OB Ioffe - University of Maryland, Baltimore, MD 32 Overexpression of the Sialyated Glycoprotein Podocalyxcin Denotes a Poor Prognosis Subset of Breast Cancers (131) DG Huntsman, N Makretsov, L Prentice, A Somasiri, M Cheang, K Gelmon, K McNagny, B Gilks, C Roskelley - Genetic Pathology Evaluation Centre; Univeristy of British Columbia; British Columbia Cancer Agency, Vancouver, BC, Canada 33 AMACR Is Overexpressed in High Grade Invasive Carcinomas of the Breast (211) AK Witkiewicz MA Rubin, CG Kleer - Brigham and Womens Hospital, Boston, MA; University of Michigan, Ann Arbor, MI 34 The Expression of Fascin, an Actin Bundling Motility-Associated Protein in Breast Cancer (215) BJ Yoder, E Tso, M Skacel, T Choueiri, S Tarr, T Budd, RR Tubbs, J Adams, AE Dawson, DG Hicks - Cleveland Clinic Foundation, Taussig Cancer Center; Lerner Research Institute, Cleveland, OH 35 Peroxisome Proliferator-Activated Receptor g Expression in Invasive Breast Cancer (132) L Huo, P Kashireddy, MS Rao, LK Diaz - Feinberg School of Medicine, Northwestern Univ., Chicago, IL 36 Ovr110, a Novel Type II Membrane Protein, Is Highly Expressed in Ductal and Lobular Breast Cancer (203) B Tringler, RM Lindsay, S Salceda, R Cafferkey, R Macina, A Tobler, M Ghosh, L Corral, G Pilkington, J Papkoff, M Singh, KR Shroyer - University of Colorado Health Sciences Center, Denver, CO; diaDexus Inc., South San Francisco, CA 37 The Fragile Genes, FHIT and WWOX, Are Coordinately Inactivated in Invasive Breast Cancer: Correlations with Clinical Features (122) G Guler, A Uner, N Guler, SY Han, WW Hauck, P Mc-Cue, K Huebner - Hacettepe University, Ankara, Turkey; Hacettepe University, Ankara, Turkey; Thomas Jefferson University, Philadelphia, PA 38 The Plasminogen System and Factors Related with Tumor Cell Invasion and Metastasis Can Be Modulated by the Adenovirus E1 Gene (181) S Ramon y Cajal, M Lleonart, M Diaz, F Rojo, J Guinea, R Sanchez-Prieto, V Fernandez - Vall d'Hebron University Hospital, Barcelona, Spain; Puerta de Hierro Hospital, Madrid, Spain 39 A Novel Urokinase Receptor Splice Variant and Its Prognostic Significance in Breast Cancer (143) M Kotzsch, T Luther, A Meye, S Fuessel, K Friedrich, A Kochan, J Farthmann, M Schmitt, V Magdolen, G Baretton - TU Dresden, Dresden, Germany; TU Muenchen, Muenchen, Germany 40 LKB1 Protein Expression in Human Breast Carcinoma (111) H Fenton, B Carlile, E Montgomery, F Sahin, G Su, P Argani - Johns Hopkins Hospital, Baltimore, MD 41 Immunoexpression of Ki67 in Breast Cancer Correlates with Transcriptional Regulation of Genes Related to Apoptosis (199) PH Tan, BH Bay, S Selvarajan, P Tan, J Wu, CH Lee - Singapore General Hospital, Singapore; National University of Singapore, Singapore; National Cancer Centre, Singapore 42 Increased Expression of Y-Box Binding Protein (YB-1) in Breast Cancer Correlates with Glutathione S-Transferase (GST) pi Overexpression and Poor Prognostic Characteristics (200) PH Tan, J Huang, BH Bay, K Matsumoto, M Tsujimoto - Singapore General Hospital, Singapore; National University of Singapore, Singapore; National University of Singapore, Singapore; The Institute of Physical and Chemical Research (RIKEN), Saitama, Japan; The Institute of Physical and Chemical Research (RIKEN), Saitama, Japan 43 Different Biological Characteristics in Female and Male Breast Cancer A Comparative Study (79) S André, C Laranjeira, M Quaresma, A Pinto - Inst.PortuguLs de Oncologia Francisco Gentil CROL SA, Lisboa, Portugal 44 Identifying Prognostic Markers in Breast Cancer: Multiparameter Testing Using Tissue Microarrays (89) G Callagy, PDP Pharoah, T Sangan, D Huntsman, CB Gilks, C Caldas - Cancer Genomics Programme, University of Cambridge, Cambridge, United Kingdom; Strangeways Research Laboratories, Cambridge, United Kingdom; Department of Pathology, University of British Columbia, Vancouver, Canada 45 Use of Macrodissection in Multi-Gene RNA Analysis of Fixed Paraffin-Embedded Tumor Tissue (80) R Baehner, B Hiller, CY Kim, C Alexander, M-L Liu, M Pho, D Dutta, J Jeong, A Nguyen, M Walker, J Baker, S Shak, S Paik - NSABP, Pittsburg, PA; UCSF, San Francisco, CA; Genomic Health, Inc.